Company / Revenue
10x Genomics, Inc. Revenue History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$642.8M
FY2025
5-year range
$245.9M / $642.8M
FY2021-FY2025
Trend
+5.2%
vs FY2024
Sector context
#116 of 156
Health Care
What the data says
At $643M, 10x Genomics, Inc.'s revenue ranks #116 of 156 in the Health Care sector. Revenue has fluctuated over the past 9 years, ranging from $54M in FY2019 to $643M in FY2025.
Based on SEC 10-K filings.
$643M in FY2025 with a 5-year CAGR of +16.6%.
Improved from $619M to $643M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +29.1%
- 5-Year CAGR
- +16.6%
- 10-Year CAGR
- -
Sector benchmark
#116 of 156 in Health CareTop 74% of 156This company $642.8M Sector average $19.0B
▼
-96.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +16.6%, indicating consistent growth.
- In FY2025, revenue increased 5.2% year-over-year.
- Ranks #116 out of 156 companies in the Health Care sector.
- Lowest revenue in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -29.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $642.8M | +5.2% |
| FY2024 | $610.8M | -1.3% |
| FY2023 | $618.7M | +107.0% |
| FY2022 | $298.8M | +21.5% |
| FY2021 | $245.9M | -17.7% |
| FY2020 | $298.8M | +457.8% |
| FY2019 | $53.6M | -63.4% |
| FY2018 | $146.3M | +105.8% |
| FY2017 | $71.1M | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026